Synairgen (LON:SNG) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Synairgen plc (LON:SNGGet Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 5.02 ($0.07) and traded as low as GBX 4.30 ($0.06). Synairgen shares last traded at GBX 4.62 ($0.06), with a volume of 63,603 shares changing hands.

Synairgen Trading Down 11.8 %

The company has a market capitalization of £8.88 million, a P/E ratio of -153.83 and a beta of -2.23. The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The firm has a fifty day moving average price of GBX 3.93 and a 200-day moving average price of GBX 5.02.

About Synairgen

(Get Free Report)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.

Featured Articles

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.